AAPL344.52-3.21 (-0.92%) ▼|ABBV286.57+0.93 (+0.33%) ▲|ABT104.60+0.90 (+0.87%) ▲|ACN246.30-3.08 (-1.23%) ▼|ADBE255.70-8.12 (-3.08%) ▼|AMAT391.12+13.88 (+3.68%) ▲|AMD528.90+12.11 (+2.34%) ▲|AMGN440.95+1.69 (+0.38%) ▲|AMT190.48+1.51 (+0.80%) ▲|AMZN248.45+0.45 (+0.18%) ▲|AVGO329.90+8.22 (+2.55%) ▲|AXP314.28+1.06 (+0.34%) ▲|BA188.22-0.13 (-0.07%) ▼|BAC50.94+0.38 (+0.74%) ▲|BKNG152.02-3.82 (-2.45%) ▼|BLK1,130.41+12.16 (+1.09%) ▲|BMY61.25-0.23 (-0.37%) ▼|BNY147.79+3.15 (+2.18%) ▲|BRK-B545.29+3.10 (+0.57%) ▲|C121.74+1.12 (+0.93%) ▲|CAT692.55+7.18 (+1.05%) ▲|CL93.02-1.02 (-1.08%) ▼|CMCSA22.11-0.59 (-2.58%) ▼|COF202.84+1.50 (+0.75%) ▲|COP151.23+0.43 (+0.29%) ▲|COST1,003.60+0.28 (+0.03%) ▲|CRM243.79-4.79 (-1.93%) ▼|CSCO109.71+3.21 (+3.01%) ▲|CVS92.60-0.88 (-0.94%) ▼|CVX232.26-0.95 (-0.41%) ▼|DE637.82-8.33 (-1.29%) ▼|DHR232.14+1.64 (+0.71%) ▲|DIS110.20-2.33 (-2.07%) ▼|DUK124.54-0.45 (-0.36%) ▼|EMR161.98+0.39 (+0.24%) ▲|FDX300.33+1.61 (+0.54%) ▲|GD353.80+4.44 (+1.27%) ▲|GE288.50+2.86 (+1.00%) ▲|GEV854.16+39.16 (+4.80%) ▲|GILD158.99+2.95 (+1.89%) ▲|GM76.55+0.63 (+0.83%) ▲|GOOG316.34-0.94 (-0.30%) ▼|GOOGL319.72-0.49 (-0.15%) ▼|GS896.81+21.13 (+2.41%) ▲|HD318.47-1.37 (-0.43%) ▼|HON219.80-1.35 (-0.61%) ▼|IBM253.51-0.05 (-0.02%) ▼|INTC90.87+3.91 (+4.49%) ▲|INTU335.37-8.02 (-2.34%) ▼|ISRG453.13+0.84 (+0.19%) ▲|JNJ266.14+2.33 (+0.88%) ▲|JPM334.54+2.96 (+0.89%) ▲|KO92.45-0.26 (-0.28%) ▼|LIN510.62+1.79 (+0.35%) ▲|LLY1,281.47+8.01 (+0.63%) ▲|LMT624.04+19.86 (+3.29%) ▲|LOW198.06-0.63 (-0.31%) ▼|LRCX239.36+9.26 (+4.02%) ▲|MA613.69-9.91 (-1.59%) ▼|MCD250.37+1.91 (+0.77%) ▲|MDLZ63.00-0.81 (-1.26%) ▼|MDT94.60-0.82 (-0.85%) ▼|META642.55-0.07 (-0.01%) ▼|MMM172.70-0.77 (-0.44%) ▼|MO73.67-0.65 (-0.87%) ▼|MRK141.97-3.30 (-2.27%) ▼|MS184.21+4.72 (+2.63%) ▲|MSFT529.79+5.28 (+1.01%) ▲|MU906.74+29.19 (+3.33%) ▲|NEE82.23+0.13 (+0.16%) ▲|NFLX63.42-2.44 (-3.70%) ▼|NKE37.81+0.51 (+1.35%) ▲|NOW155.78-3.19 (-2.00%) ▼|NVDA215.56+4.60 (+2.18%) ▲|ORCL126.45+0.29 (+0.23%) ▲|PEP135.76-0.01 (-0.01%) ▼|PFE29.90-0.14 (-0.45%) ▼|PG159.85-1.17 (-0.73%) ▼|PLTR198.60+1.85 (+0.94%) ▲|PM202.40+2.93 (+1.47%) ▲|QCOM178.73+2.82 (+1.60%) ▲|RTX196.03+5.02 (+2.63%) ▲|SBUX102.14+1.34 (+1.33%) ▲|SCHW90.00-0.58 (-0.64%) ▼|SO92.69-0.20 (-0.22%) ▼|SPG212.86+1.23 (+0.58%) ▲|T20.92-0.02 (-0.07%) ▼|TMO679.06+5.24 (+0.78%) ▲|TMUS145.53-1.02 (-0.69%) ▼|TSLA394.39+22.17 (+5.96%) ▲|TXN291.80+7.11 (+2.50%) ▲|UBER66.33-0.37 (-0.55%) ▼|UNH411.11-6.98 (-1.67%) ▼|UNP294.93+2.06 (+0.70%) ▲|UPS100.08-0.98 (-0.97%) ▼|USB59.85+0.27 (+0.45%) ▲|V403.66-4.26 (-1.04%) ▼|VZ43.17-1.50 (-3.35%) ▼|WFC83.11+0.72 (+0.87%) ▲|WMT120.57+0.68 (+0.57%) ▲|XOM183.77+0.56 (+0.30%) ▲|AAPL344.52-3.21 (-0.92%) ▼|ABBV286.57+0.93 (+0.33%) ▲|ABT104.60+0.90 (+0.87%) ▲|ACN246.30-3.08 (-1.23%) ▼|ADBE255.70-8.12 (-3.08%) ▼|AMAT391.12+13.88 (+3.68%) ▲|AMD528.90+12.11 (+2.34%) ▲|AMGN440.95+1.69 (+0.38%) ▲|AMT190.48+1.51 (+0.80%) ▲|AMZN248.45+0.45 (+0.18%) ▲|AVGO329.90+8.22 (+2.55%) ▲|AXP314.28+1.06 (+0.34%) ▲|BA188.22-0.13 (-0.07%) ▼|BAC50.94+0.38 (+0.74%) ▲|BKNG152.02-3.82 (-2.45%) ▼|BLK1,130.41+12.16 (+1.09%) ▲|BMY61.25-0.23 (-0.37%) ▼|BNY147.79+3.15 (+2.18%) ▲|BRK-B545.29+3.10 (+0.57%) ▲|C121.74+1.12 (+0.93%) ▲|CAT692.55+7.18 (+1.05%) ▲|CL93.02-1.02 (-1.08%) ▼|CMCSA22.11-0.59 (-2.58%) ▼|COF202.84+1.50 (+0.75%) ▲|COP151.23+0.43 (+0.29%) ▲|COST1,003.60+0.28 (+0.03%) ▲|CRM243.79-4.79 (-1.93%) ▼|CSCO109.71+3.21 (+3.01%) ▲|CVS92.60-0.88 (-0.94%) ▼|CVX232.26-0.95 (-0.41%) ▼|DE637.82-8.33 (-1.29%) ▼|DHR232.14+1.64 (+0.71%) ▲|DIS110.20-2.33 (-2.07%) ▼|DUK124.54-0.45 (-0.36%) ▼|EMR161.98+0.39 (+0.24%) ▲|FDX300.33+1.61 (+0.54%) ▲|GD353.80+4.44 (+1.27%) ▲|GE288.50+2.86 (+1.00%) ▲|GEV854.16+39.16 (+4.80%) ▲|GILD158.99+2.95 (+1.89%) ▲|GM76.55+0.63 (+0.83%) ▲|GOOG316.34-0.94 (-0.30%) ▼|GOOGL319.72-0.49 (-0.15%) ▼|GS896.81+21.13 (+2.41%) ▲|HD318.47-1.37 (-0.43%) ▼|HON219.80-1.35 (-0.61%) ▼|IBM253.51-0.05 (-0.02%) ▼|INTC90.87+3.91 (+4.49%) ▲|INTU335.37-8.02 (-2.34%) ▼|ISRG453.13+0.84 (+0.19%) ▲|JNJ266.14+2.33 (+0.88%) ▲|JPM334.54+2.96 (+0.89%) ▲|KO92.45-0.26 (-0.28%) ▼|LIN510.62+1.79 (+0.35%) ▲|LLY1,281.47+8.01 (+0.63%) ▲|LMT624.04+19.86 (+3.29%) ▲|LOW198.06-0.63 (-0.31%) ▼|LRCX239.36+9.26 (+4.02%) ▲|MA613.69-9.91 (-1.59%) ▼|MCD250.37+1.91 (+0.77%) ▲|MDLZ63.00-0.81 (-1.26%) ▼|MDT94.60-0.82 (-0.85%) ▼|META642.55-0.07 (-0.01%) ▼|MMM172.70-0.77 (-0.44%) ▼|MO73.67-0.65 (-0.87%) ▼|MRK141.97-3.30 (-2.27%) ▼|MS184.21+4.72 (+2.63%) ▲|MSFT529.79+5.28 (+1.01%) ▲|MU906.74+29.19 (+3.33%) ▲|NEE82.23+0.13 (+0.16%) ▲|NFLX63.42-2.44 (-3.70%) ▼|NKE37.81+0.51 (+1.35%) ▲|NOW155.78-3.19 (-2.00%) ▼|NVDA215.56+4.60 (+2.18%) ▲|ORCL126.45+0.29 (+0.23%) ▲|PEP135.76-0.01 (-0.01%) ▼|PFE29.90-0.14 (-0.45%) ▼|PG159.85-1.17 (-0.73%) ▼|PLTR198.60+1.85 (+0.94%) ▲|PM202.40+2.93 (+1.47%) ▲|QCOM178.73+2.82 (+1.60%) ▲|RTX196.03+5.02 (+2.63%) ▲|SBUX102.14+1.34 (+1.33%) ▲|SCHW90.00-0.58 (-0.64%) ▼|SO92.69-0.20 (-0.22%) ▼|SPG212.86+1.23 (+0.58%) ▲|T20.92-0.02 (-0.07%) ▼|TMO679.06+5.24 (+0.78%) ▲|TMUS145.53-1.02 (-0.69%) ▼|TSLA394.39+22.17 (+5.96%) ▲|TXN291.80+7.11 (+2.50%) ▲|UBER66.33-0.37 (-0.55%) ▼|UNH411.11-6.98 (-1.67%) ▼|UNP294.93+2.06 (+0.70%) ▲|UPS100.08-0.98 (-0.97%) ▼|USB59.85+0.27 (+0.45%) ▲|V403.66-4.26 (-1.04%) ▼|VZ43.17-1.50 (-3.35%) ▼|WFC83.11+0.72 (+0.87%) ▲|WMT120.57+0.68 (+0.57%) ▲|XOM183.77+0.56 (+0.30%) ▲|
16.7 C
New York
Monday, October 26, 2026

Tag: European Union

Transaction in Own Shares

Transaction in Own Shares

U.S. Department of Defense Awards $6.2M to Golden Metal Resources for the Pilot Mountain Project

LONDON, July 23, 2025 /PRNewswire/ -- Guardian Metal Resources plc (AIM: GMET, OTCQX:GMTLF) is very pleased to announce that its wholly-owned subsidiary Golden Metal Resources...

U.S. Department of Defense Awards $6.2M to Golden Metal Resources for the Pilot Mountain Project

LONDON, July 23, 2025 /PRNewswire/ -- Guardian Metal Resources plc (AIM: GMET, OTCQX:GMTLF) is very pleased to announce that its wholly-owned subsidiary Golden Metal Resources...

Singapore-Based Innovative Biomedical Start-Up Achieves ‘Strategic Triumph’ to Conquer Chinese Med-Tech Market

NMPA grants Syntellix product approval for the world's most important future market with more than 1.4 billion people Syntellix' product approval for China...

Singapore-Based Innovative Biomedical Start-Up Achieves ‘Strategic Triumph’ to Conquer Chinese Med-Tech Market

NMPA grants Syntellix product approval for the world's most important future market with more than 1.4 billion people Syntellix' product approval for China...

European poultry at WOFEX 2025: The EU champions quality, sustainability, and transparency

MANILA, Philippines, July 23, 2025 /PRNewswire/ -- The European poultry sector will mark its presence at this year's World Food Expo (WOFEX) on 6–9th...

European poultry at WOFEX 2025: The EU champions quality, sustainability, and transparency

MANILA, Philippines, July 23, 2025 /PRNewswire/ -- The European poultry sector will mark its presence at this year's World Food Expo (WOFEX) on 6–9th...

Rhythm Pharmaceuticals to Report Second Quarter 2025 Financial Results on Tuesday, August 5, 2025

BOSTON, July 22, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Tuesday, August 5, 2025 to report its second quarter 2025 financial results and provide a corporate update.

Transaction in Own Shares

Transaction in Own Shares

Tariff Rates Skyrocket—Economists Finally Discover Gravity

President Trump, the self-proclaimed "tariff man," seems to have a peculiar hobby: reviving relics of past economic blunders by advocating for tariffs reminiscent of...

Lecanemab four-year efficacy and safety data to be presented at AAIC 2025

STOCKHOLM, July 22, 2025 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai will present the latest findings on lecanemab (Leqembi®), including...

Neuraxpharm continues international expansion with launch of Neuraxpharm Australia

Avendran Naidu appointed Head of Commercial to lead new affiliate CNS specialist continues growth strategy outside Europe to commercialise CNS treatments, including Nuvigil® (armodafinil), Modavigil®...

Neuraxpharm continues international expansion with launch of Neuraxpharm Australia

Avendran Naidu appointed Head of Commercial to lead new affiliate CNS specialist continues growth strategy outside Europe to commercialise CNS treatments, including Nuvigil® (armodafinil), Modavigil®...

EISAI TO PRESENT FOUR-YEAR EFFICACY AND SAFETY DATA ON CONTINUOUS TREATMENT WITH LECANEMAB AT THE ALZHEIMER’S ASSOCIATION INTERNATIONAL CONFERENCE 2025

Latest findings from Eisai's robust Alzheimer's disease (AD) pipeline include results from lecanemab long-term data, an immunoassay for measuring amyloid-β protofibrils in cerebrospinal fluid,...

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsEuropean Union